A detailed history of True Wealth Design, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 350 shares of SRPT stock, worth $8,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350
Previous 10 3400.0%
Holding current value
$8,403
Previous $171,000 3844.44%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$11.93 - $21.97 $4,056 - $7,469
340 Added 3400.0%
350 $6.75 Million
Q2 2025

Aug 06, 2025

BUY
$17.1 - $63.66 $85 - $318
5 Added 100.0%
10 $171,000
Q1 2025

May 13, 2025

BUY
$63.82 - $127.89 $127 - $255
2 Added 66.67%
5 $320,000
Q4 2024

Feb 14, 2025

SELL
$104.54 - $137.94 $104 - $137
-1 Reduced 25.0%
3 $365,000
Q3 2024

Nov 14, 2024

BUY
$124.33 - $156.75 $124 - $156
1 Added 33.33%
4 $500,000
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $339 - $491
3 New
3 $474,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $2.1B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.